NCT06753968Completed
The Role of Natural Orifice Specimen Extraction Surgery (NOSES) in Treating Right-sided Colon Cancer
Source: ClinicalTrials.gov · Last updated 31 Dec 2024
Brief summary (registry, in English)
The purpose of this study is to investigate the short-term and long-term outcomes between natural orifice specimen extraction surgery (NOSES) and totally laparoscopic right hemicolectomy (TLRH). The hypothesis is that NOSES could achieve good short-term and oncological outcomes for right colon cancer patients.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 349 (actual)
- First submitted
- 22 Dec 2024
- Start date
- 1 Jan 2018
- Primary completion date
- 1 Jan 2024
- Lead sponsor
- National Cancer Center, China
- Diseases
- Colorectal cancer
- NCT number
- NCT06753968
What you commit to
- Study type: Interventional
- Participants enrolled: 349
- From 1 Jan 2018 to the primary completion date, 1 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Significant organ dysfunction or other significant diseases, including clinically relevant coronary artery disease, cardiovascular disease, or myocardial infarction within the 12 months before enrollment; severe neurological or psychiatric history; severe infection; active disseminated intravascular coagulation;
- Alcohol abuse or drug addiction;
- Concurrent uncontrolled medical condition;
Other illness
- Hepatitis activity and peripheral neuropathy (such as peripheral neuritis, pseudo meningitis, motor neuritis, and sensory impairment);
Other
- Complete intestinal obstruction;
- Pregnancy or breastfeeding;
Who the study is looking for
- Biopsy proven colon carcinoma;
- Imaging diagnosis of T1-3 colon cancer;
- The tumor located in the cecum, ascending colon, or colonic hepatic flexure;
- Written informed consent;
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National Cancer Center, Beijing, Beijing 100000 Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.